Is VSTM Worth Buying in 2026?

Verastem, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Verastem, Inc. (VSTM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: above the 50-day MA (medium-term momentum positive); strong 1-year return of +32.7%. Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-1.88% over 10 days); RSI 77 — overbought, elevated pullback risk. Currently 41.5% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

VSTM is trading below its 200-day MA ($7.44) — a key warning sign the longer-term trend is under pressure. With an RSI of 77.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +32.7% compares to +35.1% for SPY (trailed the market by 2.4%). The current 41.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $13,266 today
vs. S&P 500 (SPY) — same period trailed market by 2.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($7.44)
Above 50-day MA ($5.80)
!RSI(14) neutral zone (30–70) — currently 77.1
Positive return (+32.7%)
!Within 10% of period high (−41.5%)
Period Range $6.58
$4.01 $11.25
RSI (14) 77.1
0 · OversoldOverbought · 100

Key Metrics

Price$6.58
Period Return+32.7%
Period High$11.25
Period Low$4.01
Drawdown−41.5%
MA-50$5.80
MA-200$7.44
RSI (14)77.1
Avg Volume (30d)2.2M
vs. SPYtrailed by 2.4%
Return Rank#479 of 996

Trade VSTM

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers